These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 36140032)

  • 1. Minocycline and the SPR741 Adjuvant Are an Efficacious Antibacterial Combination for
    Alamneh YA; Antonic V; Garry B; Pucci MJ; Abu-Taleb R; Shearer JP; Demons ST; Getnet D; Swierczewski BE; Lister T; Zurawski DV
    Antibiotics (Basel); 2022 Sep; 11(9):. PubMed ID: 36140032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SPR741, an Antibiotic Adjuvant, Potentiates the
    Zurawski DV; Reinhart AA; Alamneh YA; Pucci MJ; Si Y; Abu-Taleb R; Shearer JP; Demons ST; Tyner SD; Lister T
    Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28947471
    [No Abstract]   [Full Text] [Related]  

  • 3. A Whole-Cell Screen Identifies Small Bioactives That Synergize with Polymyxin and Exhibit Antimicrobial Activities against Multidrug-Resistant Bacteria.
    Zimmerman SM; Lafontaine AJ; Herrera CM; Mclean AB; Trent MS
    Antimicrob Agents Chemother; 2020 Feb; 64(3):. PubMed ID: 31844003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potentiation of Antibiotic Activity by a Novel Cationic Peptide: Potency and Spectrum of Activity of SPR741.
    Corbett D; Wise A; Langley T; Skinner K; Trimby E; Birchall S; Dorali A; Sandiford S; Williams J; Warn P; Vaara M; Lister T
    Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28533232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Analysis of distribution and drug resistance of pathogens from the wounds of 1 310 thermal burn patients].
    Zhang C; Gong YL; Luo XQ; Liu MX; Peng YZ
    Zhonghua Shao Shang Za Zhi; 2018 Nov; 34(11):802-808. PubMed ID: 30481922
    [No Abstract]   [Full Text] [Related]  

  • 6. SPR741, Double- or Triple-Combined With Erythromycin and Clarithromycin, Combats Drug-Resistant
    She P; Liu Y; Xu L; Li Y; Li Z; Liu S; Hussain Z; Wu Y
    Front Cell Infect Microbiol; 2022; 12():858606. PubMed ID: 35372124
    [No Abstract]   [Full Text] [Related]  

  • 7. Triple combination of SPR741, clarithromycin, and erythromycin against Acinetobacter baumannii and its tolerant phenotype.
    Li Z; She P; Liu Y; Xu L; Li Y; Liu S; Hussain Z; Li L; Yang Y; Wu Y
    J Appl Microbiol; 2023 Jan; 134(1):. PubMed ID: 36626755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Analysis of the pathogenic characteristics of 162 severely burned patients with bloodstream infection].
    Gong YL; Yang ZC; Yin SP; Liu MX; Zhang C; Luo XQ; Peng YZ
    Zhonghua Shao Shang Za Zhi; 2016 Sep; 32(9):529-35. PubMed ID: 27647068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The polymyxin derivative NAB739 is synergistic with several antibiotics against polymyxin-resistant strains of Escherichia coli, Klebsiella pneumoniae and Acinetobacter baumannii.
    Tyrrell JM; Aboklaish AF; Walsh TR; Vaara T; Vaara M
    Peptides; 2019 Feb; 112():149-153. PubMed ID: 30586602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergistic effect between nisin and polymyxin B against pandrug-resistant and extensively drug-resistant Acinetobacter baumannii.
    Thomas VM; Brown RM; Ashcraft DS; Pankey GA
    Int J Antimicrob Agents; 2019 May; 53(5):663-668. PubMed ID: 30880230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular characterization of multidrug-resistant ESKAPEE pathogens from clinical samples in Chonburi, Thailand (2017-2018).
    Ruekit S; Srijan A; Serichantalergs O; Margulieux KR; Mc Gann P; Mills EG; Stribling WC; Pimsawat T; Kormanee R; Nakornchai S; Sakdinava C; Sukhchat P; Wojnarski M; Demons ST; Crawford JM; Lertsethtakarn P; Swierczewski BE
    BMC Infect Dis; 2022 Aug; 22(1):695. PubMed ID: 35978294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluorescence High-Throughput Screening for Inhibitors of TonB Action.
    Nairn BL; Eliasson OS; Hyder DR; Long NJ; Majumdar A; Chakravorty S; McDonald P; Roy A; Newton SM; Klebba PE
    J Bacteriol; 2017 May; 199(10):. PubMed ID: 28242720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. From Breast Cancer to Antimicrobial: Combating Extremely Resistant Gram-Negative "Superbugs" Using Novel Combinations of Polymyxin B with Selective Estrogen Receptor Modulators.
    Hussein MH; Schneider EK; Elliott AG; Han M; Reyes-Ortega F; Morris F; Blastovich MAT; Jasim R; Currie B; Mayo M; Baker M; Cooper MA; Li J; Velkov T
    Microb Drug Resist; 2017 Jul; 23(5):640-650. PubMed ID: 27935770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distribution and Drug Resistance of Bacterial Pathogens Associated with Lower Respiratory Tract Infection in Children and the Effect of COVID-19 on the Distribution of Pathogens.
    Zhu X; Ye T; Zhong H; Luo Y; Xu J; Zhang Q; Luo X; Wang Q; Zhang L; Song P; Zhang J
    Can J Infect Dis Med Microbiol; 2022; 2022():1181283. PubMed ID: 35368516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pandrug-resistant Gram-negative bacteria: the dawn of the post-antibiotic era?
    Falagas ME; Bliziotis IA
    Int J Antimicrob Agents; 2007 Jun; 29(6):630-6. PubMed ID: 17306965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paradoxical Effect of Polymyxin B: High Drug Exposure Amplifies Resistance in Acinetobacter baumannii.
    Tsuji BT; Landersdorfer CB; Lenhard JR; Cheah SE; Thamlikitkul V; Rao GG; Holden PN; Forrest A; Bulitta JB; Nation RL; Li J
    Antimicrob Agents Chemother; 2016 Jul; 60(7):3913-20. PubMed ID: 27067330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New antibiotic agents: problems and prospects.
    Weber DJ; Rutala WA
    Surg Infect (Larchmt); 2005; 6 Suppl 2():S-97-107. PubMed ID: 23577500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms Underlying Synergistic Killing of Polymyxin B in Combination with Cannabidiol against
    Hussein M; Allobawi R; Levou I; Blaskovich MAT; Rao GG; Li J; Velkov T
    Pharmaceutics; 2022 Apr; 14(4):. PubMed ID: 35456620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibacterial Activity of 1-[(2,4-Dichlorophenethyl)amino]-3-Phenoxypropan-2-ol against Antibiotic-Resistant Strains of Diverse Bacterial Pathogens, Biofilms and in Pre-clinical Infection Models.
    Defraine V; Verstraete L; Van Bambeke F; Anantharajah A; Townsend EM; Ramage G; Corbau R; Marchand A; Chaltin P; Fauvart M; Michiels J
    Front Microbiol; 2017; 8():2585. PubMed ID: 29312259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of Antimicrobial Effects of a New Polymyxin Molecule (SPR741) When Tested in Combination with a Series of β-Lactam Agents Against a Challenge Set of Gram-Negative Pathogens.
    Mendes RE; Rhomberg PR; Lister T; Cotroneo N; Rubio A; Flamm RK
    Microb Drug Resist; 2020 Apr; 26(4):319-328. PubMed ID: 31596663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.